Johnson & Johnson has granted Stop TB Partnership license to produce generic bedaquiline in low and middle-income countries
33
votes
-
-
An open letter to Johnson & Johnson regarding its strategy to extend its patent on bedaquiline leading to a predicted six million lives lost over four years
79 votes -
Moderna drops vaccine patent in ninety-two low income countries
14 votes -
Opinion: Stop private speculation in COVID-19 research
5 votes -
How big pharma was captured by the one percent
4 votes